COX-2与PTEN在大肠癌组织中表达的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的:探讨PTEN与COX-2在大肠癌组织中的表达及与大肠癌生物学特性的关系。
     方法:应用免疫组织化学染色法对48例大肠癌组织、20例大肠腺瘤组织和20例正常大肠粘膜组织进行免疫组织化学染色,COX-2以试剂公司提供的阳性表达的结肠癌切片作为阳性对照, PTEN以试剂公司提供的阳性表达的扁桃体切片作为阳性对照,以PBS置换一抗作为阴性对照。结果采用阳性细胞数和染色强度得分相乘法,分别计为“-、+、++、+++”。按此等级应用χ2检验分析COX-2和PTEN的表达情况及与大肠癌生物学特性的关系;并应用Spearman检验分析COX-2与PTEN在大肠癌中表达的关系。
     结果:1. COX-2表达定位于细胞胞浆中,大肠癌、大肠腺瘤、正常大肠组织中的表达率分别为79.2%、50.0%、15.0%,各组间比较差异有统计学意义(P<0.05)。
     2. COX-2表达与大肠癌生物学特性的关系:COX-2在大肠癌中的表达与淋巴结转移、Dukes分期有相关性,而与性别、年龄、肿瘤大小、肿瘤部位及肿瘤组织分化程度无相关性。大肠癌组织中COX-2在淋巴结转移中的表达率91.7%明显高于无淋巴结转移的66.7%,差异有统计学意义(P<0.05);DukesC、D期COX-2的表达率(92.3%)明显高于DukesA、B期的表达率(63.6%),差异有统计学意义(P<0.05)。
     3. PTEN表达定位于细胞核,大肠癌、大肠腺瘤、正常大肠粘膜组织中的表达率分别为33.3%、60.0%、95.0%,各组间比较差异有统计学意义(P<0.05)。
     4. PTEN表达与大肠癌生物学特性的关系: PTEN在大肠癌中的表达与淋巴结转移及Dukes分期相关,而与性别、年龄、肿瘤大小、肿瘤部位及肿瘤组织分化程度无相关性。伴淋巴结转移中PTEN的表达率为14.6%,无淋巴结转移中PTEN的表达率为50.0%,两组间差异有统计学意义(P<0.05)。DukesC、D期的表达率为19.2%,A、B期的表达率为50.0%,两组间比较差异有统计学意义(P<0.05)。
     5.PTEN和COX-2在大肠癌中表达的相关性本组38例COX-2表达阳性的标本中,PTEN阳性表达9例,阴性表达29例;10例COX-2表达阴性的标本中,PTEN阳性表达7例,阴性表达3例;二者呈负相关,r=-0.326, P<0.05。
     结论:1.COX-2在大肠癌组织中的表达率明显高于其在大肠腺瘤、正常大肠粘膜组织中的表达。COX-2在大肠癌中的表达与淋巴结转移和Dukes分期相关,而与性别、年龄、肿瘤大小、肿瘤部位及肿瘤组织分化程度无相关性。
     2.PTEN在大肠癌组织中的表达率明显低于其在大肠腺瘤、正常大肠粘膜组织中的表达。PTEN在大肠癌中的表达与淋巴结转移及Dukes分期相关,而与性别、年龄、肿瘤大小、肿瘤部位及组织分化程度无相关性。
     3.COX-2和PTEN在大肠癌组织中的表达呈负相关( r=-0.326,P<0.05),提示COX-2和PTEN在大肠癌发生发展过程中起重要的负向协同作用。
Objective: To investigate the expressions of COX-2 and PTEN in colorectal carcinoma and their correlations with the bionomics of colorectal carcinoma.
     Methods: The expressions of COX-2 and PTEN protein were deter- mined by immunohistochemical staining (Streptavidin-Peroxidase/ S-P method) in the tissues of 48 colorectal carcinoma, 20 colorectal adenomas and 20 normal colorectal mucous .Based on dying strength and masculine cell population ,the results were divided as“-,+,++,+++”. The data was analyzed by software SPSS11.5. The difference of COX-2 and PTEN expression in the different pathological classifications of colorectal carcinoma was analyzed with Chi-square Test. Spearman method was used to analyze the relationship between COX-2 and PTEN expression in the colorectal carcinoma.
     Results: (1).The positive staining of COX-2 mainly located in cytoplasm. The rate of COX-2 expression was 79.2% in colorectal carci- noma group, 50.0% in colorectal adenoma and 15.0% in the normal colore- ctal mucous membrane group respectively. There were significant differences among the there groups (P<0.05). The expression of COX-2 had relationship with lymphatic metastasis and Dukes stages, but had no relationship with sexuality, age,size ,position and histological differentia- tion. The rate of COX-2 expression was 91.7% in colorectal carcinoma group with lymphatic metastasis and 66.7% in colorectal carcinoma group without lymphatic metastasis. A significant difference was observed between the two groups (P<0.05). The rate of COX-2 expression was higher in the group of Dukes C and D stages than that in the group of Dukes A and B stages (P<0.05).(2).The positive staining of PTEN mainly located in the nucleus of colorectal carcinoma tissues. The rate of PTEN expression was 33.3% in colorectal carcinoma group, 60.0% positive expression in the colorectal adenoma and 95.0% positive expression in normal colorectal mucous membrane group respectively. There were statistically significant differences among the there groups (P<0.05). The expression of PTEN had relationship with lymphatic metastasis and Dukes stages, but had no relationship with sexuality, age, size, position and histological differentia- tion. The rate of PTEN expression was 14.6% in colorectal carcinoma group with lymphatic metastasis and 50.0% in colorectal carcinoma group without lymphatic metastasis. A significant difference was observed between the two groups (P<0.05).The rate of PTEN expression was 50.0% in the group of Dukes A and B stages and 19.2% in the group of Dukes C and D stages. The positive expression rate of A and B stages was higher than that of C and D stages (P<0.05). (3).Of the 38 specimens with positive COX-2,9 had the positive expression of PTEN; of the 10 specimens with negative COX-2,7 had the positive expression of PTEN. There was a negative correlation between COX-2 and PTEN(r=-0.326, P<0.05).
     Conclusion:(1). COX-2 is highly expressed in colorectal carcinoma tissues,but it is lowly expressed in adenoma and normal tissues. The expression of COX-2 is related to lymphatic metastasis and Dukes stages. But it has no relationship with sexuality, age,size ,position and histological differentiation. (2). PTEN is lowly expressed in colorectal carcinoma and colocrectal adenoma tissues, but it is highly expressed in normal colorectal mucous membrane. The expression of PTEN has relationship with lymphatic metastasis and Dukes stages ,but it is not related to sexuality, age,size ,position and histological differentiation. (3). COX-2 and PTEN play an important role in the carcinogenesis of colorectal carcinoma. The expression of COX-2 is negative related to that of PTEN in colorectal carcinoma tissues.
引文
1. Yamauchi T,Wayanabe M,Kubtoa,T,et al.Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer[J].Dis Colon Rectum,2002,45:98- 103.
    2. Wenzel U et al.Cancer Res,2000;60(14):3823-3831.
    3. Masunnage R,Kohno H,Dhar DK et al.Cyclooxygenase-2 expressin correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients[J].Clin cancer Res,2000,6:4064-4068.
    4. Tomozawa S,Tsumo NH,Sunaml E,et al.Cyclooxygenase-2 over expression corre- lates with tumor recurrence especially hematogenous metastasis of colorectal cancer[J].Br J Cancer,2006,61:324-328.
    5. Sheng HM,Shao TY ,Dubois RN.K-Ras mediated in crease in cyclooxygenase- 2mRNA stability involves activation of the protein kinase B[J].C ancei Res 2001,61:2670-2675.
    6. Subbaramaish K,Altorki N,Chunf WJ,et al.Inhabition of cyclooxygenase-2 gene expression by p53[J].J Biol chem 1999,274:10911-10915.
    7. Zachary I,Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor[J].Am J Physiol Cell Physiol,2001,280(6):1375-1386.
    8. Tsujii M,Kawano S,Dubios R N.Cyclooxygenase-2 expression in human colon cancer cells increases metatatic potential[J].Proc Natl Acad Sci USA,19997, 94 (7): 3336-3340.
    9. Noda M,Tatsumi Y,Tomizawa M,et al.Effects of etodolac a selective COX-2 inhibitor ; on the expression of E-Catenin complex in gastrointestinal cell line[J].J Gastroenterol,2002,37(11):896-904.
    10. Tsujii M,Dubosis RN, Alterations in cellulai adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J].Cell,1995,83:493-512.
    11. Wikstrom K,Juhas M,Sjolander A.The anti-apoptotic effect of leukoyriene D4 involves the prevention of caspase B activation and Bid cleavage[J].Biochem J,2003,371:115-124.
    12. Reddy BS,Hirose Y,Dher DK etal. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor,celecoxib,administered during different stages ofcarcinogenesis[J].Cancer Res,2000,60:293-297.
    13. Phillips R K,Wallace M H,Lynch P M,et al.A randomized,double blind,placeo controlled study of celecoxib,a selective cyclooxygenase-2 inhibitor,on duodenal polyposis in familial adenomatous polyposis[J].Gur,2002,50(6):857-860.
    14. Lin E,Morris JS,Ayers GD,effect of celecoxib on capecitabine-in-duced hand- foot syndrome and antitumor activity[J].Oncology,2002,16:S7-S31.
    15. Milas L,Mason LA,Crane CH et al.Improvement of radiotherapy or chemoradio- therapy by targeting cyclooxygenase-2 enzyme[J].Oncology (Hunting),2003,17:15-24.
    16. Li J,Yenc,Liaw Delal.PTEN,putative protein tyrosine phosphatase gene mutated in human brain,broast,and prostate Cancer[J].Science,1997,275(5308):1993.
    17. Steck PA,Pershouse MA,Jasser SA,et al.Indentification of a candidate tumor suppressor gene MMAC1 at chromosome 10q23 that is mutated in multiple advanced cancers[J].Nat Genet,1997,15(4):356-362.
    18.杨福文,胡俊波,杨传永.大肠良恶性肿瘤中PTEN的蛋白表达及其临床意义[J].临床外科杂志,2004,11(7):415-417.
    19.李季,田素礼,李巍等.结直肠癌中PTEN的缺失表达及临床意义[J].世界华人消化杂志,2006,14(28):2771-2775.
    20. Yuan XJ,Whang YE.PTEN sensitizes prostate cancer cells to death receptor- mediated and drug-induced apoptosis through a FADD-dependent pathway[J]. Oncogene ,2002,21(2):319-327.
    21. Myers MP,Pass I,Batty IH,et al.The lipid phosphate activity of PTEN is critical for its tumor suppressor function[J].Proe AcadSci USA,1998,95(23):13513- 13518.
    22. Chung MJ,Jung SH,Lee BJ ,et al.Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis,but not angiogenesis,of breast cancer[J].Pathol Int,2004,12(3):205-210.
    23. Jiang BH,Zheng JZ,Aoki M,et al.Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression and expression of vascular endothelial grow factor in endothelial calls[J].Proc Natl Acad Sci USA,2000,97(4) :1749-1753.
    24. Honio S,Osski M,Ardvanto TD,et al.COX-2 inhibitor,NS398,enhances Fas- mediated apptosisvia modulation of the PTEN-Akt pathway in human gastic carcinoma cell lines[J].DNA Cell Biol,2005,24(3):141.
    25. Rahman MA,Kyriazanos ID,Ono T,et al.Impact of PTEN expression on the outcome of hepatitis C virua-positive cirrhotic hepatocellar caicinoma patients; possible relationship with COX-2 and inducible nitric oxide synthase [J].IntJ Cancer,2002,100(2):152.
    26. Pore N,Liu S,Shu FIK,et al.Spl is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism[J].Mol Biol Cell,2004, 15(11):4841.
    1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world caner burden: Globocan 2003[J].Int J Cancer 2004,94(2):153-156.
    2.曹歌,沈志祥.前列腺素与结直肠肿瘤.世界华人消化杂志,2001,9:431-434.
    3. Kinoshita T, Takahashi Y, Sakashita T, et al. Growth stimulation and induction of epidermal growth factor receptor by overex pression of cyclooxygenases 1 and
    2 in human colon carcinoma cells. Biochim Biophys Acta 1999,1438:120-130.
    4. Hla T, Neilson K.Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992,89:7384-7388.
    5. Tomaozawa S, Nagawa H, Tsumno N, et al. Inhibition of haematogenous meta- stasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522,Br J Cancer 1999,81:1274-1279.
    6. Lynch PM.COX-2 inhibition in clinical cancer prevention, Oncology(Hungting) 2001,15:21-26.
    7. Murata H, Kawano S,T suji S, et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma.Am J Gastroen- terol 1999,94:451-455.
    8. Li G,Yang T,Yan J.Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 2002,299:866-890.
    9. Sun B, Wu YL, Zhang XJ, et al. Effects of Sulindac on growth inhibition and apoptosis induction in human gastric cancer cells. Shijie Huaren Xiaohua Zazhi 2001,9:997-1002.
    10. Wu YL, Sun B, Zhang XJ ,et al. Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells. World J Gastroenterol 2001,7:796-800.
    11. Tsujii M, Kawano S, Tsuji S, et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998,93:705-716.
    12. Cianchi F, Cortesini C, Bechi P, et al. Up-regulation of cyclooxygenase-2 gene expression correlates with tumor angiogenesis in human colorectal cancer, Gastroenterology 2001,121:1339-1347.
    13. Daniel TO, Liu H, Morrow JD, Crews BC, et al. Thromboxane A2 is a mediator of cyclooxygenase-2-depedent endothelial migration and angiogenesis. Cancer Res 1999,59:4574-4577.
    14. Tian G, Yu JP, Luo HS, et al. Effect of Nimesulide on proliferation and apoptosisof human hepatoma SMMC-7721cells.World J Gastroenerol 2002,8:483-487.
    15. Ramaswang S, Nakamura n, Vazquez F, et al. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phospha- tidylinositol 3-kinase/Akt pathway. Rroc Natl Acad Sci USA,1999,96 (5):2110.
    16. Hwang PH, Yi HK, Kim DS, et al. Suppression of tumorigenicity and metastasis in B16F10 cells by PTEN/MMAC1/TEP1 Gene.Cancer Lett,2001,172(1):83.
    17. Hamilton SR, Anltonen LA.WHO classification of tumors pathology and genetics-tunors of digestive system .Lyon: IARC press,2000,11-32.
    18. Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-likedrugs[J].NatNewBiol,1971,231(25):232-235.
    19. Smith W L, Meade EA, DeWitt D L. Interactions of PGH synthase isozumes-1 and -2 with NSAIDs[J].Biochim J,1994,302(3):723-727.
    20. Chu AJ, Chou TH, Chen BD. Prevention of colorectal cancer using COX-2 inhibitors: basic science and clinical applications. Front Biosci, 2004, 9:2697- 2713.
    21. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and 2 in human colorectal cancer. Cancer Res,1996,56(11):2556-2560.
    22.徐菁,李士瑛,兰向昀.环氧合酶-2,c-erbB-2和Ki67在结直肠癌中表达及临床意义.解剖学杂志,2005,28(3).
    23. Joo YE, Kim HS, Min SW, et al. Expression of cyclooxygenase-2 protein in colorectal caicinoma[J].Int J Castrointest Cancer,2002,31(1-3):147-154.
    24. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase mutated in human brain, breast, and prostate cancer[J].Science,1997, 275(5308): 1943-1947.
    25. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a cancidate tumour suppressor gene,MMAC1,atchromosome 10q23.3 that is mutated in multiple advanced cancers[J],Nat Genet,1997,15(4):356-362.
    26. Dicuonzo G, Angelitti S, Garcia-Foneillas J, et al. Colorectal carcinomas and PTEN/MMAC1 gene mutation[J]. Clin Cancer Res,2001,7(12):4049-4053.
    27.何细松,曾昭淳,刘万里.PCR-LIS-SSCP检测大肠癌PTEN基因的点突变[J].实用癌症杂志,2002,17(1):28-30.
    28.杨福文,胡俊波,杨传永.大肠良恶性肿瘤中PTEN的蛋白表达及其临床意义[J].临床外科杂志,2004,12(7):415.
    29. Tamura M, Gu J. Inhibition of cell migration, spreading and focal adhesion bytumor suppressor PTEN,1998,280(5369):1614.
    30. Lillental J, Moon SY, Lesche R, et al. Genetic deletion of the PTEN tumor suppressor gene promotes cell motility by activation of Racl and Cdc42 GTPase, Curr Biol,2000,10(7):401.
    31. Jiang YA, Fan LF, Jiang CO, et al. Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinoma [J].World J Gastroenterol ,2003,9(3):491-494.
    32. St-Germain ME, Gagnon V, Mathieu I, et al. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells[J].Int J Oncol,2004,24(5):1311-24.
    33. Covey TM, Edes K, Fitazatrick FA. Akt activation by arachidonic acid meta- bolism occurs via oxidation and inactivation of PTEN tumor suppressor[J]. On- cogene , 2007,19(3).
    34. Honjo S, OsakiM, Ardyanb TD, et al.COX-2 inhibitor,NS398,enhances fas -mediatded apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines[J].DNA Cell Biol,2005,24(3):141-7.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700